[Emergency contraception: CNGOF Contraception Guidelines]

Gynecol Obstet Fertil Senol. 2018 Dec;46(12):799-805. doi: 10.1016/j.gofs.2018.10.006. Epub 2018 Oct 30.
[Article in French]

Abstract

Objectives: Edit, by the French National College of Gynecologists and Obstetricians (CNGOF), recommendations based on the evidence available in the literature for the use in terms of effectiveness, safety and side effects of emergency contraception (EC).

Methods: A review of the literature was conducted by consulting Medline, Cochrane Library and international recommendations in French and English from January 1, 1979 to May 1, 2018.

Results: It is recommended to inform patients that EC is not 100% effective. A pregnancy test is recommended if there is a delay after taking an EC. It is recommended to use EC as soon as possible after the unprotected intercourse. In the absence of long-term contraception, in the first 72hours after unprotected intercourse, ulipristal acetate (UPA) and levonorgestrel (LNG) may be offered with a superiority of UPA from 0 to 72h. Beyond 72hours, the data suggest a better efficiency of the UPA. However, taking into account practical elements (access to EC, cost, impact on the taking of hormonal contraception after UPA), it is difficult to recommend the UPA as a priority between 0 and 72h. Menstruation is more likely to happen early with LNG. The copper IUD is an effective method that can be used in EC until 120hours after unprotected intercourse or when there is a risk of contraceptive failure.

Conclusions: EC is not 100% effective. The closer the intake of EC with the unprotected intercourse, the more effective is the EC in terms of pregnancy rate.

Keywords: Contraception d’urgence; Dispositif intra-utérin en cuivre; Emergency contraception; Levonorgestrel; Lévonorgestrel; Post-coital copper intrauterine device; Rapports non protégés; Ulipristal acetate; Ulipristal acétate; Unprotected intercourse.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Contraception, Postcoital* / adverse effects
  • Contraception, Postcoital* / methods
  • Female
  • France
  • Humans
  • Intrauterine Devices, Copper
  • Levonorgestrel / administration & dosage
  • MEDLINE
  • Norpregnadienes / administration & dosage
  • Pregnancy
  • Pregnancy Tests
  • Unsafe Sex

Substances

  • Norpregnadienes
  • Levonorgestrel
  • ulipristal acetate